Dermata Therapeutics, Inc. (DRMA)

NASDAQ: DRMA · IEX Real-Time Price · USD

1.725

-0.095 (-5.20%)

At close: Jul 19, 2024, 4:00 PM

1.630

-0.095 (-5.52%)

Pre-market: Jul 22, 2024, 6:00 AM EDT

Dermata Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	4.49	3.97	4.02	4.4	1.57	1.85
Research & Development	4.48	4.07	5.65	3.46	1.61	2.62
Operating Expenses	8.97	8.04	9.67	7.86	3.17	4.47
Operating Income	-8.97	-8.04	-9.67	-7.86	-3.17	-4.47
Interest Expense / Income	0	0	0	0.05	0.2	0.25
Other Expense / Income	-0.28	-0.25	-0.06	-	-0.13	-
Pretax Income	-8.69	-7.79	-9.61	-7.9	-3.24	-4.72
Net Income	-8.69	-7.79	-9.61	-7.9	-3.24	-4.72
Preferred Dividends	0	0	0	2.56	0	0
Net Income Common	-8.69	-7.79	-9.61	-10.46	-3.24	-4.72
Shares Outstanding (Basic)	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0
Shares Change	575.65%	323.42%	156.86%	125.12%	-	-
EPS (Basic)	-27.75	-40.05	-208.80	-583.20	-405.60	-592.80
EPS (Diluted)	-27.75	-40.05	-208.80	-583.20	-405.60	-592.80
Free Cash Flow	-7.46	-6.41	-8.83	-5.69	-4.03	-3.92
Free Cash Flow Per Share	-16.81	-32.87	-191.86	-317.61	-505.94	-492.59
EBITDA	-8.69	-7.79	-9.61	-7.86	-3.04	-4.47
Depreciation & Amortization	0	0	0	0	0	0
EBIT	-8.69	-7.79	-9.61	-7.86	-3.04	-4.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).